Liposomal Copermeation Assay Reveals Unexpected Membrane Interactions of Commonly Prescribed Drugs
Molecular Pharmaceutics · 03.06.2024 · 21 (6) · 2673-2683
DOI: 10.1021/acs.molpharmaceut.3c00766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 29.04.2024. Verfasst von Klára Odehnalová und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 5, Prague 6 166 28, Czech Republic. Hauptthemen laut MEDLINE: Liposomes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grantov? Agentura Cesk? Republiky, Univerzita Palack?ho v Olomouci, CzechELib project.
Abstract (Originalsprache)
The permeation of small molecules across biological membranes is a crucial process that lies at the heart of life. Permeation is involved not only in the maintenance of homeostasis at the cell level but also in the absorption and biodistribution of pharmacologically active substances throughout the human body. Membranes are formed by phospholipid bilayers that represent an energy barrier for permeating molecules. Crossing this energy barrier is assumed to be a singular event, and permeation has traditionally been described as a first-order kinetic process, proportional only to the concentration gradient of the permeating substance. For a given membrane composition, permeability was believed to be a unique property dependent only on the permeating molecule itself. We provide experimental evidence that this long-held view might not be entirely correct. Liposomes were used in copermeation experiments with a fluorescent probe, where simultaneous permeation of two substances occurred over a single phospholipid bilayer. Using an assay of six commonly prescribed drugs, we have found that the presence of a copermeant can either enhance or suppress the permeation rate of the probe molecule, often more than 2-fold in each direction. This can have significant consequences for the pharmacokinetics and bioavailability of commonly prescribed drugs when used in combination and provide new insight into so-far unexplained drug-drug interactions as well as changing the perspective on how new drug candidates are evaluated and tested.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 5, Prague 6 166 28, Czech Republic.
- Zentiva, k.s., U Kabelovny 130, Prague 10 102 37, Czech Republic.
- Department of Physical Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 12, Olomouc 771 46, Czech Republic.
- Department of Organic Technology, University of Chemistry and Technology Prague, Technická 5, Prague 6 166 28, Czech Republic.
- Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague 6 162 00, Czech Republic.
ORCID-Profile: Klára Odehnalová, Magdalena Konefał, Karel Berka, Jiří Brus, František Štěpánek
Förderung
- Grantov? Agentura Cesk? Republiky
- Univerzita Palack?ho v Olomouci
- CzechELib project
Zitieren
APA
Odehnalová, K., Balouch, M., Storchmannová, K., Petrová, E., Konefał, M., Zadražil, A., Berka, K., Brus, J., & Štěpánek, F. (2024). Liposomal Copermeation Assay Reveals Unexpected Membrane Interactions of Commonly Prescribed Drugs. Molecular Pharmaceutics, 21(6), 2673-2683. https://doi.org/10.1021/acs.molpharmaceut.3c00766
Vancouver
Odehnalová K, Balouch M, Storchmannová K, Petrová E, Konefał M, Zadražil A, et al. Liposomal Copermeation Assay Reveals Unexpected Membrane Interactions of Commonly Prescribed Drugs. Molecular Pharmaceutics. 2024;21(6):2673-2683. doi:10.1021/acs.molpharmaceut.3c00766
BibTeX
@article{Odehnalov2024,
author = {Odehnalová, Klára and Balouch, Martin and Storchmannová, Kateřina and Petrová, Eliška and Konefał, Magdalena and Zadražil, Aleš and Berka, Karel and Brus, Jiří and Štěpánek, František},
title = {Liposomal Copermeation Assay Reveals Unexpected Membrane Interactions of Commonly Prescribed Drugs},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {6},
pages = {2673--2683},
doi = {10.1021/acs.molpharmaceut.3c00766}
}
EUVIMED